Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

The Safety of Different Dose Levels of Zidovudine in HIV-Infected Children

ClinicalTrials.gov ID: NCT00000983

Public ClinicalTrials.gov record NCT00000983. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 18, 2026, 9:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Blinded Trial To Evaluate the Safety and Tolerance of High Versus Low Dose Zidovudine Administered to Children With Human Immunodeficiency Virus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate and compare differences in tolerance and side effects associated with two different dosages of zidovudine (AZT) when used to treat children with HIV infection. Other goals are to evaluate and compare the degree of change in neurodevelopmental disease and determine whether there are differences in the rate and degree of toxicities associated with one versus the other dosage. AZT has been shown to decrease the death rate and frequency of opportunistic infections in certain adult patients with symptomatic HIV infection. Thus, it is likely that symptomatic HIV infected children may also benefit from AZT. Studies of the safety and pharmacokinetics (blood levels) in children have indicated that AZT can be given to children in doses that can be tolerated and that can be assumed to be therapeutic. Those currently taking care of infected children no longer feel it is ethical to conduct an AZT/placebo (inactive substance) trial. In addition, given the information learned from studies of adult patients that shows effectiveness of AZT at lower doses, experience with an equivalent lower dose in children needs to be studied.

Study identification

NCT ID
NCT00000983
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
400 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
3 Months to 12 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Nov 30, 1994
Last update posted
Nov 3, 2021

Ends 1994

United States locations

U.S. sites
48
U.S. states
15
U.S. cities
31
Facility City State ZIP Site status
Kaiser Permanente / UCLA Med Ctr Downey California 902422814
Long Beach Memorial (Pediatric) Long Beach California 90801
Children's Hosp of Los Angeles/UCLA Med Ctr Los Angeles California 900276016
Los Angeles County - USC Med Ctr Los Angeles California 90033
Cedars Sinai / UCLA Med Ctr Los Angeles California 900481804
UCLA Med Ctr / Pediatric Los Angeles California 900951752
Children's Hosp of Oakland Oakland California 946091809
Univ of California / San Diego Treatment Ctr San Diego California 921036325
Northern California Pediatric AIDS Treatment Ctr / UCSF San Francisco California 94143
Univ of Connecticut Health Ctr / Pediatrics Farmington Connecticut 06032
Children's Natl Med Ctr Washington D.C. District of Columbia 20010
Ctr for Special Immunology Fort Lauderdale Florida 33308
Univ of Miami School of Medicine Miami Florida 33136
Emory Univ School of Medicine Atlanta Georgia 30303
Cook County Hosp Chicago Illinois 60612
Univ of Illinois College of Medicine Chicago Illinois 60612
Chicago Children's Memorial Hosp Chicago Illinois 606143394
Univ of Maryland at Baltimore / Univ Med Ctr Baltimore Maryland 21201
Johns Hopkins Hosp - Pediatric Baltimore Maryland 212874933
Children's Hosp of Boston Boston Massachusetts 021155724
Boston Med Ctr Boston Massachusetts 02118
Univ of Massachusetts Med Ctr Worcester Massachusetts 01655
Children's Hosp of New Jersey / UMDNJ - New Jersey Med Schl Newark New Jersey 071072198
SUNY / Health Sciences Ctr at Brooklyn / Pediatrics Brooklyn New York 11203
Jewish Hosp Ctr of Long Island / Pediatrics Jamaica New York 11432
Schneider Children's Hosp / Long Island Jewish Med Ctr New Hyde Park New York 11042
Beth Israel Med Ctr / Pediatrics New York New York 10003
Bellevue Hosp / New York Univ Med Ctr New York New York 10016
Cornell Univ Med College New York New York 10021
Saint Luke's - Roosevelt Hosp Ctr New York New York 10025
Metropolitan Hosp Ctr New York New York 10029
Mount Sinai Med Ctr New York New York 10029
Columbia Univ Babies' Hosp New York New York 10032
Harlem Hosp Ctr New York New York 10037
Univ of Rochester Medical Center Rochester New York 14642
Lincoln Hosp Ctr / Pediatrics The Bronx New York 10451
Bronx Lebanon Hosp Ctr The Bronx New York 10456
Albert Einstein College of Medicine The Bronx New York 10461
Westchester Hosp / New York Med College / Pediatrics Valhalla New York 10595
Univ of North Carolina Chapel Hill North Carolina 275997215
Duke Univ Med Ctr Durham North Carolina 277103499
Bowman Gray School of Medicine / North Carolina Baptist Hosp Winston-Salem North Carolina 27103
Holmes Hosp / Univ of Cincinnati Med Ctr Cincinnati Ohio 452670405
Columbus Children's Hosp Columbus Ohio 432052696
Hemophilia Ctr of Western PA / Univ of Pittsburgh Pittsburgh Pennsylvania 15219
Julio Arroyo West Columbia South Carolina 29169
Hermann Hosp / Univ Texas Health Science Ctr Houston Texas 77030
Texas Children's Hosp / Baylor Univ Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00000983, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 3, 2021 · Synced Sep 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00000983 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →